Literature DB >> 3316462

Inhibition of NK and ADCC activity by antibodies against purified cytoplasmic granules from rat LGL tumors.

C W Reynolds1, D Reichardt, M Henkart, P Millard, P Henkart.   

Abstract

Highly purified preparations of cytoplasmic granules from transplantable rat large granular lymphocyte (LGL) tumor lines (rat natural killer (RNK) tumors) were used to immunize rabbits. Antibodies from these animals gave two precipitin lines with granule extracts in Ouchterlony experiments. They reacted with at least four different bands on nitrocellulose blots of SDS gels of LGL granule proteins. By immunofluorescence, specifically adsorbed antigranule antibodies did not recognize LGL or T cell surface antigens but reacted with the cytoplasmic granules in permeabilized RNK tumor cells as well as with normal rat LGL. These same antisera showed little or no reactivity with a panel of other cells, including peripheral blood T cells, thymocytes, macrophages, and EL-4 tumor cells. F(ab')2 preparations of these antigranule antibodies completely blocked granule-mediated lysis of both SRBC and nucleated targets, while control F(ab')2 preparations from rabbits immunized with EL-4 granules or TNP-KLH showed no significant inhibition of this cytolytic activity at the same antibody concentration. Anti-granule F(ab')2 preparations specifically inhibited (greater than 75%) rat natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities in a dose-dependent manner but did not effect cytotoxic T cell activity. Pretreatment of either effectors or targets by these antibodies had no effect. Anti-granule F(ab')2 preparations, at concentrations showing strong inhibition of lysis, did not inhibit the binding of LGL to YAC-1 or Ab-coated P815 targets. These results demonstrate that a granule component(s) is necessary for the lytic activity of LGL in both NK and ADCC and provide the first direct evidence that a secretory event involving these granules is part of the lytic process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316462     DOI: 10.1002/jlb.42.6.642

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.

Authors:  L H Young; C S Foster; J D Young
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

2.  Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms.

Authors:  D S Ucker; J D Wilson; L D Hebshi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

3.  Two proteins targeted to the same lytic granule compartment undergo very different posttranslational processing.

Authors:  J K Burkhardt; S Hester; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.

Authors:  B C Schlesinger; L Cheng
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

5.  Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.

Authors:  A Hameed; K J Olsen; L Cheng; W M Fox; R H Hruban; E R Podack
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

6.  The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments.

Authors:  J K Burkhardt; S Hester; C K Lapham; Y Argon
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.

Authors:  K Hiruma; H Nakamura; P A Henkart; R E Gress
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

8.  Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.

Authors:  P Zanovello; A Rosato; V Bronte; V Cerundolo; S Treves; F Di Virgilio; T Pozzan; G Biasi; D Collavo
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.

Authors:  S Yano; S Sone; Y Nishioka; M Naito; T Tsuruo; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.